Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1999 Apr;83(4):425–428. doi: 10.1136/bjo.83.4.425

Dopamine use is an indicator for the development of threshold retinopathy of prematurity

M Mizoguchi 1, T Chu 1, F Murphy 1, N Willits 1, L Morse 1
PMCID: PMC1723003  PMID: 10434864

Abstract

AIM—To assess whether treatment of premature infants with dopamine is a risk factor for development of retinopathy of prematurity (ROP).
METHODS—A retrospective case series analysis of two groups was utilised with a minimum follow up of 6 months. Clinical profiles and patient risk factors were identified along with an evaluation of ROP progression and an analysis of clinical outcome. All infants were seen in a single community neonatal intensive care unit (NICU). 41 consecutive high risk infants were identified during a 36 month period whose birth weight was less than 1000 grams and who remained in the NICU without transfer until at least 28 days of age. Dilated indirect ophthalmoscopy fundus examinations were performed on all infants to identify the degree of and progression to threshold ROP.
RESULTS—18 of 41 infants were treated with dopamine for hypotension. The group of infants requiring dopamine differed statistically from the non-dopamine treated group by having a slightly higher birth weight, a greater incidence of hypotension and colloid treatment, and in manifesting more advanced respiratory disease. Within the dopamine treated group, 12 of 18 infants (67%) reached prethreshold ROP and seven infants (39%) reached threshold ROP requiring laser treatment. In contrast, only three of the infants (13%) who did not require dopamine for hypotension progressed to prethreshold (p=0.001) and only one of these infants (4%) progressed to threshold ROP (p = 0.02). Logistic regression analysis among other variables demonstrated that dopamine use and gestational age are important factors in this low birthweight population for predicting the development of threshold ROP (dopamine use: adjusted odds ratio = 119.88, p = 0.0061; gestational age: adjusted odds ratio = 0.061, p = 0.0043).
CONCLUSIONS—Dopamine use in low birthweight infants may therefore be a risk factor for the development of threshold ROP. More vigilant screening of high risk infants requiring dopamine therapy for systemic hypotension may be warranted.

 Keywords: dopamine; retinopathy of prematurity; infants

Full Text

The Full Text of this article is available as a PDF (105.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Batton D. G., Roberts C., Trese M., Maisels M. J. Severe retinopathy of prematurity and steroid exposure. Pediatrics. 1992 Oct;90(4):534–536. [PubMed] [Google Scholar]
  2. Ben Sira I., Nissenkorn I., Kremer I. Retinopathy of prematurity. Surv Ophthalmol. 1988 Jul-Aug;33(1):1–16. doi: 10.1016/0039-6257(88)90068-9. [DOI] [PubMed] [Google Scholar]
  3. Benner J. D., Morse L. S., Hay A., Landers M. B., 3rd A comparison of argon and diode photocoagulation combined with supplemental oxygen for the treatment of retinopathy of prematurity. Retina. 1993;13(3):222–229. doi: 10.1097/00006982-199313030-00006. [DOI] [PubMed] [Google Scholar]
  4. Biglan A. W., Cheng K. P., Brown D. R. Update on retinopathy of prematurity. Int Ophthalmol Clin. 1989 Spring;29(1):2–9. doi: 10.1097/00004397-198902910-00002. [DOI] [PubMed] [Google Scholar]
  5. Brown D. R., Biglan A. W., Stretavsky M. M. Retinopathy of prematurity: the relationship with intraventricular hemorrhage and bronchopulmonary dysplasia. J Pediatr Ophthalmol Strabismus. 1990 Sep-Oct;27(5):268–271. doi: 10.3928/0191-3913-19900901-13. [DOI] [PubMed] [Google Scholar]
  6. Campbell P. B., Bull M. J., Ellis F. D., Bryson C. Q., Lemons J. A., Schreiner R. L. Incidence of retinopathy of prematurity in a tertiary newborn intensive care unit. Arch Ophthalmol. 1983 Nov;101(11):1686–1688. doi: 10.1001/archopht.1983.01040020688003. [DOI] [PubMed] [Google Scholar]
  7. Dowling J. E. Retinal neuromodulation: the role of dopamine. Vis Neurosci. 1991 Jul-Aug;7(1-2):87–97. doi: 10.1017/s0952523800010968. [DOI] [PubMed] [Google Scholar]
  8. Ferrari-Dileo G., Davis E. B., Anderson D. R. Effects of cholinergic and adrenergic agonists on adenylate cyclase activity of retinal microvascular pericytes in culture. Invest Ophthalmol Vis Sci. 1992 Jan;33(1):42–47. [PubMed] [Google Scholar]
  9. Ferrari-Dileo G., Davis E. B., Anderson D. R. Response of retinal vasculature to phenylephrine. Invest Ophthalmol Vis Sci. 1990 Jun;31(6):1181–1182. [PubMed] [Google Scholar]
  10. Gibson D. L., Sheps S. B., Schechter M. T., Wiggins S., McCormick A. Q. Retinopathy of prematurity: a new epidemic? Pediatrics. 1989 Apr;83(4):486–492. [PubMed] [Google Scholar]
  11. Gibson D. L., Sheps S. B., Uh S. H., Schechter M. T., McCormick A. Q. Retinopathy of prematurity-induced blindness: birth weight-specific survival and the new epidemic. Pediatrics. 1990 Sep;86(3):405–412. [PubMed] [Google Scholar]
  12. Gunn T. R., Easdown J., Outerbridge E. W., Aranda J. V. Risk factors in retrolental fibroplasia. Pediatrics. 1980 Jun;65(6):1096–1100. [PubMed] [Google Scholar]
  13. Hammer M. E., Mullen P. W., Ferguson J. G., Pai S., Cosby C., Jackson K. L. Logistic analysis of risk factors in acute retinopathy of prematurity. Am J Ophthalmol. 1986 Jul 15;102(1):1–6. doi: 10.1016/0002-9394(86)90200-x. [DOI] [PubMed] [Google Scholar]
  14. KINSEY V. E. Retrolental fibroplasia; cooperative study of retrolental fibroplasia and the use of oxygen. AMA Arch Ophthalmol. 1956 Oct;56(4):481–543. [PubMed] [Google Scholar]
  15. Landers M. B., 3rd, Toth C. A., Semple H. C., Morse L. S. Treatment of retinopathy of prematurity with argon laser photocoagulation. Arch Ophthalmol. 1992 Jan;110(1):44–47. doi: 10.1001/archopht.1992.01080130046024. [DOI] [PubMed] [Google Scholar]
  16. Laties A. M., Stone R. A. Some visual and neurochemical correlates of refractive development. Vis Neurosci. 1991 Jul-Aug;7(1-2):125–128. doi: 10.1017/s0952523800010993. [DOI] [PubMed] [Google Scholar]
  17. Nielsen P. J., Nyborg N. C. Adrenergic responses in isolated bovine retinal resistance arteries. Int Ophthalmol. 1989 Jan;13(1-2):103–107. doi: 10.1007/BF02028648. [DOI] [PubMed] [Google Scholar]
  18. Padbury J. F., Agata Y., Baylen B. G., Ludlow J. K., Polk D. H., Goldblatt E., Pescetti J. Dopamine pharmacokinetics in critically ill newborn infants. J Pediatr. 1987 Feb;110(2):293–298. doi: 10.1016/s0022-3476(87)80176-2. [DOI] [PubMed] [Google Scholar]
  19. Padbury J. F., Agata Y., Baylen B. G., Ludlow J. K., Polk D. H., Habib D. M., Martinez A. M. Pharmacokinetics of dopamine in critically ill newborn infants. J Pediatr. 1990 Sep;117(3):472–476. doi: 10.1016/s0022-3476(05)81101-1. [DOI] [PubMed] [Google Scholar]
  20. Palmer E. A., Flynn J. T., Hardy R. J., Phelps D. L., Phillips C. L., Schaffer D. B., Tung B. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1991 Nov;98(11):1628–1640. doi: 10.1016/s0161-6420(91)32074-8. [DOI] [PubMed] [Google Scholar]
  21. Palmer G. C. Neurochemical coupled actions of transmitters in the microvasculature of the brain. Neurosci Biobehav Rev. 1986 Summer;10(2):79–101. doi: 10.1016/0149-7634(86)90020-5. [DOI] [PubMed] [Google Scholar]
  22. Schaffer D. B., Palmer E. A., Plotsky D. F., Metz H. S., Flynn J. T., Tung B., Hardy R. J. Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1993 Feb;100(2):230–237. doi: 10.1016/s0161-6420(93)31665-9. [DOI] [PubMed] [Google Scholar]
  23. Stone R. A., Lin T., Iuvone P. M., Laties A. M. Postnatal control of ocular growth: dopaminergic mechanisms. Ciba Found Symp. 1990;155:45–62. doi: 10.1002/9780470514023.ch4. [DOI] [PubMed] [Google Scholar]
  24. Stone R. A., Lin T., Laties A. M., Iuvone P. M. Retinal dopamine and form-deprivation myopia. Proc Natl Acad Sci U S A. 1989 Jan;86(2):704–706. doi: 10.1073/pnas.86.2.704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Valentine P. H., Jackson J. C., Kalina R. E., Woodrum D. E. Increased survival of low birth weight infants: impact on the incidence of retinopathy of prematurity. Pediatrics. 1989 Sep;84(3):442–445. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES